Showing 1 - 12 results of 12 for search 'Alessandro Cellini', query time: 0.03s
Refine Results
-
1
-
2
A Case of Hemophagocytic Lymphohistiocytosis Triggered by Disseminated Tuberculosis and Hairy Cell Leukaemia after SARS-CoV2 Infection by Alessandro Cellini, Andrea Visentin, Massimiliano Arangio Febbo, Susanna Vedovato, Serena Marinello, Ivo Tiberio, Livio Trentin, Carmela Gurrieri
Published 2022-01-01
Article -
3
Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells by Alessandro Cellini, Federico Scarmozzino, Francesco Angotzi, Edoardo Ruggeri, Angelo Paolo Dei Tos, Livio Trentin, Marco Pizzi, Andrea Visentin
Published 2023-05-01
Article -
4
Primary Myelofibrosis Occurring during Targeted Therapy for Chronic Lymphocytic Leukemia: A Report of Two Cases by Francesco Angotzi, Andrea Visentin, Federico Scarmozzino, Alessandro Cellini, Roberta Bertorelle, Marco Pizzi, Gianni Binotto, Angelo Paolo Dei Tos, Livio Trentin
Published 2022-02-01
Article -
5
From Biology to Treatment of Monoclonal Gammopathies of Neurological Significance by Andrea Visentin, Stefano Pravato, Francesca Castellani, Marta Campagnolo, Francesco Angotzi, Chiara Adele Cavarretta, Alessandro Cellini, Valeria Ruocco, Alessandro Salvalaggio, Alessandra Tedeschi, Livio Trentin, Chiara Briani
Published 2022-03-01
Article -
6
A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Def... by Andrea Visentin, Maria Chiara Molinari, Stefano Pravato, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavaretta, Valeria Ruocco, Silvia Imbergamo, Francesco Piazza, Giulia Proietti, Francesca Romana Mauro, Livio Trentin
Published 2022-12-01
Article -
7
P054: The Kinase CK2 is deregulated and targetable in classical Hodgkin Lymphoma by Andrea Visentin, Edoardo Ruggeri, Federica Frezzato, Marco Pizzi, Alessandro Cellini, Francesco Angotzi, Chiara Adele Cavarretta, Valeria Ruocco, Stefano Pravato, Filippo Severin, Monica Facco, Sabrina Manni, Francesci Piazza, Livio Trentin
Published 2022-10-01
Article -
8
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course by Francesco Angotzi, Alessandro Cellini, Valeria Ruocco, Chiara Adele Cavarretta, Ivan Zatta, Andrea Serafin, Stefano Pravato, Elisa Pagnin, Laura Bonaldi, Federica Frezzato, Monica Facco, Francesco Piazza, Livio Trentin, Andrea Visentin
Published 2024-03-01
Article -
9
P1075: ADVANCED-STAGE CHL INTERNATIONAL PROGNOSTICATION INDEX: EXTERNAL VALIDATION IN A SINGLE-CENTER RETROSPECTIVE PATIENT DATASET AND COMPARISON TO THE HASENCLEVER IPS by Alessandro Cellini, Chiara Adele Cavarretta, Francesco Angotzi, Valeria Ruocco, Andrea Serafin, Ivan Zatta, Michele Gregianin, Stefania Vio, Filippo Crimì, Federica Vianello, Marco Pizzi, Stefano Pravato, Livio Trentin, Andrea Visentin
Published 2023-08-01
Article -
10
P005: Age, histotype and stage IV are associated with a shorter survival in patients with Hodgkin lymphoma, even the PET-adapted era. A single center retrospective study. by Andrea Visentin, Alessandro Cellini, Chiara Adele Cavarretta, Leila Romano Gargarella, Francesco Angotzi, Valeria Ruocco, Simone Zoletto, Stefano Pravato, Marco Pizzi, Federica Vianello, Filippo Crimì, Stefania Vio, Michele Gregianin, Livio Trentin
Published 2022-10-01
Article -
11
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies by Francesco Angotzi, Marco Petrella, Tamara Berno, Gianni Binotto, Giorgia Bonetto, Antonio Branca, Marco Carraro, Chiara Adele Cavaretta, Alessandro Cellini, Fabio D’Amore, Laura Forlani, Ilaria Gianesello, Carmela Gurrieri, Silvia Imbergamo, Federica Lessi, Antonio Maroccia, Federica Mazzetto, Laura Pavan, Sara Pezone, Francesco Piazza, Stefano Pravato, Valeria Ruocco, Greta Scapinello, Fabrizio Vianello, Renato Zambello, Ivan Zatta, Simone Zoletto, Andrea Padoan, Livio Trentin, Andrea Visentin
Published 2023-06-01
Article -
12
Obinutuzumab plus chlorambucil versus ibrutinib in previously untreated chronic lymphocytic leukemia patients without TP53 disruptions: A real-life CLL campus study by Andrea Visentin, Andrea Visentin, Francesca Romana Mauro, Gioachino Catania, Alberto Fresa, Candida Vitale, Alessandro Sanna, Veronica Mattiello, Francesca Cibien, Paolo Sportoletti, Massimo Gentile, Gian Matteo Rigolin, Francesca Maria Quaglia, Roberta Murru, Alessandro Gozzetti, Stefano Molica, Monia Marchetti, Stefano Pravato, Francesco Angotzi, Alessandro Cellini, Lydia Scarfò, Gianluigi Reda, Marta Coscia, Luca Laurenti, Paolo Ghia, Robin Foà, Antonio Cuneo, Livio Trentin, Livio Trentin
Published 2022-11-01
Article